Capital Fund Management (CFM)
AVDL

Capital Fund Management (CFM)’s Avadel Pharmaceuticals AVDL Stock Holding History

Capital Fund Management (CFM)’s Portfolio AVDL Stock Details AVDL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-52,100
Closed -$575K – 1513
2016
Q1 		$575K Buy
+52,100
New +$517K 0.01% 1083

Other funds holding AVDL

BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
JGC
J. Goldman & Co New York $3.44B AUM 33.8% 1-Year Est. Return
FPC
Falcon Point Capital San Francisco, California $11.9M AUM 55.76% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
PCM
Portolan Capital Management Boston, Massachusetts $1.88B AUM 115.74% 1-Year Est. Return

Capital Fund Management (CFM)'s AVDL Position: Q2 2016 in Review

Capital Fund Management (CFM) sold out of Avadel Pharmaceuticals (AVDL) in Q2 2016, closing a stake of 52,100 shares — an estimated $575K sold.

Capital Fund Management (CFM) first reported a position in AVDL in Q1 2016 and held it in 1 quarter. The position peaked at $575K in Q1 2016. 84 funds tracked by Wall St. Rank hold AVDL as of Q2 2016.

  • Capital Fund Management (CFM) reported no remaining Avadel Pharmaceuticals position as of Q2 2016 after selling out during the quarter.
  • Capital Fund Management (CFM) sold 52,100 Avadel Pharmaceuticals shares in Q2 2016, an estimated $575K.
  • Capital Fund Management (CFM) first reported a position in Avadel Pharmaceuticals in Q1 2016 and held it in 1 quarter.
  • Capital Fund Management (CFM)'s Avadel Pharmaceuticals position peaked at $575K in Q1 2016.
  • 84 funds tracked by Wall St. Rank held Avadel Pharmaceuticals as of Q2 2016.

Based on Capital Fund Management (CFM)'s 13F filing for Q2 2016, filed 27 Jul 2016.